Invasive Breast Carcinoma Active Not Recruiting Phase 3 Trials for Tamoxifen (DB00675)

Also known as: Invasive carcinoma of breast / Breast cancer invasive NOS

IndicationStatusPhase
DBCOND0031787 (Invasive Breast Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00601900Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast CancerTreatment
NCT01272037Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerTreatment